C the Signs
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease. In under 30 seconds, C the Signs can rapidly identify…
C the Signs
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease. In under 30 seconds, C the Signs can rapidly identify…
TL;DR
What they do: AI platform to identify patients at risk of cancer at earlier, more treatable stages
Founders / leadership: Founded by NHS doctors Dr Bea (Bhavagaya) Bakshi (CEO) and Dr Miles Payling (Chief Scientific Officer)
Product reach: Integrates with major NHS EMRs and supports FHIR/HL7
Security & compliance: Holds certifications including ISO 27001 and Cyber Essentials PLUS; HIPAA and GDPR compliance claimed
Funding signal: Multiple funding rounds; most-recent disclosed round led by Khosla Ventures (Jan 30, 2025)
Company Overview
Problem Domain
Early cancer detection in primary care
Founded
2017
Industry
Hospitals and Health Care
Tech Stack
Funding Track Record
Most recent disclosed round listed on company profiles
Investor Signal
“Has completed multiple funding rounds (reported as 6) and lists investors including Khosla Ventures and CancerX Startup Accelerator”
Founders
What we do
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |